AAAAAA
Results:
1-20
|
Results: 20
Authors:
Rappl, G
Abken, H
Hasselmann, DO
Tilgen, W
Ugurel, S
Reinhold, U
Citation: G. Rappl et al., The CD7(-) subset of CD4(+) memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15), CELL DEAT D, 8(4), 2001, pp. 395-402
Authors:
Ugurel, S
Rappl, G
Tilgen, W
Reinhold, U
Citation: S. Ugurel et al., Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients, CLIN CANC R, 7(5), 2001, pp. 1282-1286
Authors:
Hasselmann, DO
Rappl, G
Rossler, M
Ugurel, S
Tilgen, W
Reinhold, U
Citation: Do. Hasselmann et al., Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma, ONCOL REP, 8(1), 2001, pp. 115-118
Authors:
Gross, T
Wagner, A
Ugurel, S
Tilgen, W
Reinhold, U
Citation: T. Gross et al., Identification of TIA-1+and granzyme B plus cytotoxic T cells in lichen sclerosus et atrophicus, DERMATOLOGY, 202(3), 2001, pp. 198-202
Authors:
Seiter, S
Ugurel, S
Tilgen, W
Reinhold, U
Citation: S. Seiter et al., High-dose pulse corticosteroid therapy in the treatment of severe alopeciaareata, DERMATOLOGY, 202(3), 2001, pp. 230-234
Authors:
Reinhold, U
Berkin, C
Bosserhoff, AK
Deutschmann, A
Garbe, C
Glaser, R
Hein, R
Krahn, G
Peter, RU
Rappl, G
Schittek, B
Seiter, S
Ugurel, S
Volkenandt, M
Tilgen, W
Citation: U. Reinhold et al., Interlaboratory evaluation of a new reverse transcriptase polymerase chainreaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: A multicenter study of the dermatologic cooperativeoncology group, J CL ONCOL, 19(6), 2001, pp. 1723-1727
Authors:
Ugurel, S
Rappl, G
Tilgen, W
Reinhold, U
Citation: S. Ugurel et al., Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival, J CL ONCOL, 19(2), 2001, pp. 577-583
Authors:
Rappl, G
Muche, JM
Abken, H
Sterry, W
Tilgen, W
Ugurel, S
Reinhold, U
Citation: G. Rappl et al., CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome, J AM ACAD D, 44(3), 2001, pp. 456-461
Authors:
Rappl, G
Kapsokefalou, A
Heuser, C
Rossler, M
Ugurel, S
Tilgen, W
Reinhold, U
Abken, H
Citation: G. Rappl et al., Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha, J INVES DER, 116(1), 2001, pp. 102-109
Authors:
Ugurel, S
Rebmann, V
Ferrone, S
Tilgen, W
Grosse-Wilde, H
Reinhold, U
Citation: S. Ugurel et al., Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy, CANCER, 92(2), 2001, pp. 369-376
Authors:
Hauschild, A
Garbe, C
Stolz, W
Ellwanger, U
Seiter, S
Dummer, R
Ugurel, S
Sebastian, G
Nashan, D
Linse, R
Achtelik, W
Mohr, P
Kaufmann, R
Fey, M
Ulrich, J
Tilgen, W
Citation: A. Hauschild et al., Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG), BR J CANC, 84(8), 2001, pp. 1036-1042
Authors:
Reinhold, U
Ugurel, S
Tilgen, W
Kadiata, MM
Olivares, E
Nadi, AB
Malaisse, WJ
Citation: U. Reinhold et al., Antitumoral action of 2-deoxy-D-glucose tetraacetate in human melanoma cells, ONCOL REP, 7(5), 2000, pp. 1093-1097
Authors:
Pfohler, C
Ugurel, S
Seiter, S
Wagner, A
Tilgen, W
Reinhold, U
Citation: C. Pfohler et al., Interferon-alpha-associated development of bullous lesions in mycosis fungoides, DERMATOLOGY, 200(1), 2000, pp. 51-53
Authors:
Seiter, S
Ugurel, S
Tilgen, W
Reinhold, U
Citation: S. Seiter et al., Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo, INT J DERM, 39(8), 2000, pp. 624-627
Authors:
Ugurel, S
Pfoiiler, C
Tilgen, W
Reinhold, U
Citation: S. Ugurel et al., S100-beta serum protein - a new marker in the diagnosis and monitoring of Langerhans cell histiocytosis?, BR J DERM, 143(1), 2000, pp. 201-202
Authors:
Seiter, S
Ugurel, S
Pfohler, C
Tilgen, W
Reinhold, U
Citation: S. Seiter et al., Successful treatment of progressive vitiligo with high-dose intravenous methylprednisolone 'pulse' therapy, DERMATOLOGY, 199(3), 1999, pp. 261-262
Authors:
Seiter, S
Ugurel, S
Tilgen, W
Reinhold, U
Citation: S. Seiter et al., Multiple granular cell tumors and growth hormone deficiency in a child, PEDIAT DERM, 16(4), 1999, pp. 308-310
Authors:
Reinhold, U
Seiter, S
Ugurel, S
Tilgen, J
Citation: U. Reinhold et al., Treatment of progressive pigmented purpura with oral bioflavonoids and, ascorbic acid: An open pilot study in 3 patients, J AM ACAD D, 41(2), 1999, pp. 207-208
Authors:
Ugurel, S
Seiter, S
Rappl, G
Stark, A
Tilgen, W
Reinhold, U
Citation: S. Ugurel et al., Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma, INT J CANC, 82(5), 1999, pp. 727-736
Authors:
Seiter, S
Gantenbein, C
Ugurel, S
Ruprecht, KW
Tilgen, W
Reinhold, U
Citation: S. Seiter et al., An oculocutaneous presentation of essential progressive telangiectasia, BR J DERM, 140(5), 1999, pp. 969-971
Risultati:
1-20
|